Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07893067) titled 'Efficacy and Safety of Triple-Combination Cream Plus Microneedling Along With Tranexamic Acid Versus Platelet-Rich Plasma in the Treatment of Moderate-to-Severe Melasma: A Randomized Comparative Study' on Oct. 19.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Bangladesh Medical University

Condition: Melasma (Facial Melasma)

Intervention: Drug: Group B (Triple Combination Cream + Microneedling + Platelet-Rich Plasma)

Recruitment Status: Not recruiting

Phase: Phase 4

Date of Fir...